Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroki Kakuta

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 2, 2011
[Challenge of creating single-agents for the treatment of type 1 and 2 diabetes by targeting retinoid X receptor]Hiroki Kakuta
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 4, 2019
[Problems with Laboratory Notebooks in Academia and How to Resolve Them]Hiroki Kakuta
International Journal of Molecular Sciences|August 15, 2018
Retinoid X Receptor AntagonistsMasaki Watanabe, Hiroki Kakuta
Journal of Medicinal Chemistry|April 27, 2021
In Vivo Receptor Visualization and Evaluation of Receptor Occupancy with Positron Emission TomographyYuta Takamura, Hiroki Kakuta
Expert Opinion on Therapeutic Patents|January 25, 2014
Retinoid X receptor ligands: a patent review (2007 - 2013)Shoya Yamada, Hiroki Kakuta
Current Topics in Medicinal Chemistry|June 21, 2016
Retinoid X Receptor Ligands with Anti-Type 2 Diabetic ActivityKen-Ichi Morishita, Hiroki Kakuta
International Immunopharmacology|July 1, 2014
Involvement of glucocorticoid receptor activation on anti-inflammatory effect induced by peroxisome proliferator-activated receptor γ agonist in miceAtsuki Yamamoto, Hiroki Kakuta, Yukio Sugimoto
Chemical & Pharmaceutical Bulletin|November 6, 2003
Specific nonpeptide inhibitors of puromycin-sensitive aminopeptidase with a 2,4(1H,3H)-quinazolinedione skeletonHiroki Kakuta, Aya Tanatani, Kazuo Nagasawa, et al.
PPAR Research|December 23, 2011
Involvement of the Retinoid X Receptor Ligand in the Anti-Inflammatory Effect Induced by Peroxisome Proliferator-Activated Receptor γ Agonist In VivoAtsuki Yamamoto, Hiroki Kakuta, Hiroyuki Miyachi, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2002
Fluorescent bioprobes for visualization of puromycin-sensitive aminopeptidase in living cellsHiroki Kakuta, Yukiko Koiso, Kazuo Nagasawa, et al.
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 2, 2011
[Challenge of creating single-agents for the treatment of type 1 and 2 diabetes by targeting retinoid X receptor]Hiroki Kakuta
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 4, 2019
[Problems with Laboratory Notebooks in Academia and How to Resolve Them]Hiroki Kakuta
International Journal of Molecular Sciences|August 15, 2018
Retinoid X Receptor AntagonistsMasaki Watanabe, Hiroki Kakuta
Journal of Medicinal Chemistry|April 27, 2021
In Vivo Receptor Visualization and Evaluation of Receptor Occupancy with Positron Emission TomographyYuta Takamura, Hiroki Kakuta
Expert Opinion on Therapeutic Patents|January 25, 2014
Retinoid X receptor ligands: a patent review (2007 - 2013)Shoya Yamada, Hiroki Kakuta
Current Topics in Medicinal Chemistry|June 21, 2016
Retinoid X Receptor Ligands with Anti-Type 2 Diabetic ActivityKen-Ichi Morishita, Hiroki Kakuta
International Immunopharmacology|July 1, 2014
Involvement of glucocorticoid receptor activation on anti-inflammatory effect induced by peroxisome proliferator-activated receptor γ agonist in miceAtsuki Yamamoto, Hiroki Kakuta, Yukio Sugimoto
Chemical & Pharmaceutical Bulletin|November 6, 2003
Specific nonpeptide inhibitors of puromycin-sensitive aminopeptidase with a 2,4(1H,3H)-quinazolinedione skeletonHiroki Kakuta, Aya Tanatani, Kazuo Nagasawa, et al.
PPAR Research|December 23, 2011
Involvement of the Retinoid X Receptor Ligand in the Anti-Inflammatory Effect Induced by Peroxisome Proliferator-Activated Receptor γ Agonist In VivoAtsuki Yamamoto, Hiroki Kakuta, Hiroyuki Miyachi, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2002
Fluorescent bioprobes for visualization of puromycin-sensitive aminopeptidase in living cellsHiroki Kakuta, Yukiko Koiso, Kazuo Nagasawa, et al.
Pageof 8